Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy

Autor: Livia Tartaglione, Chiara Vismara, Federica Di Ruscio, Marta Vecchi, Alessandro Raimondi, Claudia Alteri, Luna Colagrossi, Carlo Federico Perno, Daniela Campisi, Alice Nava, Roberto Rossotti, Giovanna Travi, Diana Fanti, Roberto Fumagalli, Valeria Cento, Marco Merli, Andrea Beretta, Massimo Puoti, Filippo Galbiati, Francesco Scaglione, Oscar Massimiliano Epis, Nicola Ughi
Přispěvatelé: Cento, V, Alteri, C, Merli, M, Ruscio, F, Tartaglione, L, Rossotti, R, Travi, G, Vecchi, M, Raimondi, A, Nava, A, Colagrossi, L, Fumagalli, R, Ughi, N, Epis, O, Fanti, D, Beretta, A, Galbiati, F, Scaglione, F, Vismara, C, Puoti, M, Campisi, D, Perno, C
Rok vydání: 2020
Předmět:
RNA viruses
Male
0301 basic medicine
Viral Diseases
Pulmonology
Coronaviruses
Physiology
Artificial Gene Amplification and Extension
Antibodies
Viral

Polymerase Chain Reaction
Biochemistry
Serology
Medical Conditions
0302 clinical medicine
Seroepidemiologic Studies
Immune Physiology
030212 general & internal medicine
Young adult
Child
Pathology and laboratory medicine
Virus Testing
Aged
80 and over

Immune System Proteins
Multidisciplinary
Medical microbiology
Middle Aged
Hospitals
Titer
Infectious Diseases
Italy
Viruses
Medicine
Female
SARS CoV 2
Pathogens
Coronavirus Infections
Research Article
Adult
medicine.medical_specialty
SARS coronavirus
Adolescent
Coronavirus disease 2019 (COVID-19)
Science
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunology
Pneumonia
Viral

Research and Analysis Methods
Microbiology
Antibodies
Respiratory Disorders
Betacoronavirus
Young Adult
03 medical and health sciences
Diagnostic Medicine
Internal medicine
medicine
Humans
Seroprevalence
Molecular Biology Techniques
Molecular Biology
Pandemics
Aged
Medicine and health sciences
Biology and life sciences
SARS-CoV-2
business.industry
Organisms
Viral pathogens
Proteins
COVID-19
Covid 19
Chemiluminescent Assays
Reverse Transcriptase-Polymerase Chain Reaction
Microbial pathogens
Health Care
030104 developmental biology
Health Care Facilities
Immunoglobulin G
Respiratory Infections
Communicable Disease Control
business
Zdroj: PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0242765 (2020)
ISSN: 1932-6203
Popis: Objective Through a hospital-based SARS-CoV-2 molecular and serological screening, we evaluated the effectiveness of two months of lockdown and two of surveillance, in Milan, Lombardy, the first to be overwhelmed by COVID-19 pandemics during March-April 2020. Methods All subjects presenting at the major hospital of Milan from May-11 to July-5, 2020, underwent a serological screening by chemiluminescent assays. Those admitted were further tested by RT-PCR. Results The cumulative anti-N IgG seroprevalence in the 2753 subjects analyzed was of 5.1% (95%CI = 4.3%-6.0%), with a peak of 8.4% (6.1%-11.4%) 60–63 days since the peak of diagnoses (March-20). 31/106 (29.2%) anti-N reactive subjects had anti-S1/S2 titers >80 AU/mL. Being tested from May-18 to June-5, or residing in the provinces with higher SARS-CoV-2 circulation, were positively and independently associated with anti-N IgG reactivity (OR [95%CI]: 2.179[1.455–3.264] and 3.127[1.18–8.29], respectively). In the 18 RT-PCR positive, symptomatic subjects, anti-N seroprevalence was 33.3% (95% CI: 14.8%-56.3%). Conclusion SARS-CoV-2 seroprevalence in Milan is low, and in a downward trend after only 60–63 days since the peak of diagnoses. Italian confinement measures were effective, but the risk of contagion remains concrete. In hospital-settings, the performance of molecular and serological screenings upon admission remains highly advisable.
Databáze: OpenAIRE